| Nicholas John Hamilton, MD | |
|
2823 Fresno St, Fresno, CA 93721-1324 | |
| (559) 499-6439 | |
| (559) 499-6441 |
| Full Name | Nicholas John Hamilton |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 2823 Fresno St, Fresno, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366685927 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A102702 (California) | Primary |
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration under the President's Emergency Plan for AIDS Relief for its New Drug Application for Zidovudine Tablets, 100 mg.
In an opinion piece in the Guardian's "Comment is Free" blog, Dean Baker, co-director of the Center for Economic and Policy Research, discusses potential policies contained within the "Trans-Pacific Partnership Agreement (TPP), a pact that the United States is negotiating with Australia, Canada, Japan and eight other countries in the Pacific region."
Health Partners International of Canada (HPIC) and the Honourable Beverley J. Oda, Minister of International Cooperation, unveil a 5-year project to build the capacity of the Afghan healthcare system in the area of pharmaceutical management and to provide people in Afghanistan with $25 million in life-saving pharmaceuticals and medical supplies.
Sydney-based pharmaceutical company Pharmaxis Ltd has conducted an interim analysis on the Phase IIb clinical trial evaluating Bronchitol™ in patients with the respiratory condition bronchiectasis.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas John Hamilton, MD 155 N Fresno St, Suite 206, Fresno, CA 93701-2302 Ph: (559) 499-6443 | Nicholas John Hamilton, MD 2823 Fresno St, Fresno, CA 93721-1324 Ph: (559) 499-6439 |
News Archive
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration under the President's Emergency Plan for AIDS Relief for its New Drug Application for Zidovudine Tablets, 100 mg.
In an opinion piece in the Guardian's "Comment is Free" blog, Dean Baker, co-director of the Center for Economic and Policy Research, discusses potential policies contained within the "Trans-Pacific Partnership Agreement (TPP), a pact that the United States is negotiating with Australia, Canada, Japan and eight other countries in the Pacific region."
Health Partners International of Canada (HPIC) and the Honourable Beverley J. Oda, Minister of International Cooperation, unveil a 5-year project to build the capacity of the Afghan healthcare system in the area of pharmaceutical management and to provide people in Afghanistan with $25 million in life-saving pharmaceuticals and medical supplies.
Sydney-based pharmaceutical company Pharmaxis Ltd has conducted an interim analysis on the Phase IIb clinical trial evaluating Bronchitol™ in patients with the respiratory condition bronchiectasis.
In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."
› Verified 1 days ago
Michelle Lea Storkan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 | |
Harminder S Longia, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2615 E Clinton Ave, Fresno, CA 93703 Phone: 559-225-6100 | |
Dr. Jessie Werner, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 | |
Megann Forrest Young, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 Fax: 559-499-6441 | |
Geoffrey R Stroh, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 Fax: 559-499-6441 | |
Marc Stanley Shalit, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6439 Fax: 559-499-6441 | |
Dr. Patil Armenian, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2823 Fresno St, Fresno, CA 93721 Phone: 559-499-6440 |